Company / R&D Expense
NATURAL ALTERNATIVES INTERNATIONAL INC R&D Expense History
FY2012-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$1.5M
FY2018
5-year range
$1.0M / $1.6M
FY2014-FY2018
Trend
-6.3%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 7 years, ranging from $980,000 in FY2012 to $2M in FY2017.
Based on SEC 10-K filings.
$2M in FY2018 with a 5-year CAGR of +6.4%.
Improved from $1M to $2M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +14.5%
- 5-Year CAGR
- +6.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +6.4%, indicating consistent growth.
- In FY2018, r&d expense decreased 6.3% year-over-year.
- Peak r&d expense was recorded in FY2017.
- Lowest r&d expense in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score 4.52 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $1.5M | -6.3% |
| FY2017 | $1.6M | +45.5% |
| FY2016 | $1.1M | +10.0% |
| FY2015 | $1.0M | -16.7% |
| FY2014 | $1.2M | +9.1% |
| FY2013 | $1.1M | +12.2% |
| FY2012 | $980.0K | - |
As of FY2018 · SEC 10-K · Updated Jun 28, 2026